[Dazoxiben blocks the increase of angiotensin converting enzyme in bronchoalveolar lavage induced by free fatty acids].
D000806:Angiotensin-Converting Enzyme Inhibitors; D000818:Animals; D001794:Blood Pressure; D005230:Fatty Acids, Nonesterified / Q000494:pharmacology*; D007093:Imidazoles / Q000494:pharmacology*; D008168:Lung / Q000473:pathology; D008297:Male; D007703:Peptidyl-Dipeptidase A / Q000097:blood; D011654:Pulmonary Edema / Q000139:chemically induced; D011663:Pulmonary Surfactants / Q000378:metabolism*; D011817:Rabbits; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors*
D000806:Angiotensin-Converting Enzyme Inhibitors; D005230:Fatty Acids, Nonesterified; D007093:Imidazoles; D011663:Pulmonary Surfactants; C029166:dazoxiben; D007703:Peptidyl-Dipeptidase A; D013930:Thromboxane-A Synthase
Dazoxiben bloquea el aumento de enzima convertidora de la angiotensina en el lavado bronquioalveolar inducido por ácidos grados libres.